Several groups have provided data showing that the competitive binding of STAT3 and STAT5 dimers to DNA dictates the transcriptional regulation of certain target genes in T cells and thereby either trigger autoimmune disorders or promote tumor rejection (some examples are reported in Table 2). The gene discussed is STAT5A; the disease is neoplasm.